We have a platform of small molecules drug candidates with breakthrough potential as therapies for aging-related cognitive impairments, neurodegenerative diseases, and neurodevelopmental disorders.

Our lead compounds have been tested in vivo in lab animal models and show significant effects via both subcutaneous and oral administration.